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Gene-expression reversal of 
lncRNAs and associated mRNAs 
expression in active vs latent HIV 
infection
Madhavan Nair1,2,3,*, Vidya Sagar1,2,3,* & Sudheesh Pilakka-Kanthikeel1,2,3
Interplay between lncRNAs and mRNAs is rapidly emerging as a key epigenetic mechanism in 
controlling various cell functions. HIV can actively infect and/or can persist latently for years by 
manipulating host epigenetics; however, its molecular essence remains undiscovered in entirety. 
Here for the first time, we delineate the influence of HIV on global lncRNAs expression in monocytic 
cells lines. Our analysis revealed the expression modulation of nearly 1060 such lncRNAs which are 
associated with differentially expressed mRNAs in active and latent infection. This suggests a greater 
role of lncRNAs in regulating transcriptional and post-transcriptional gene expression during HIV 
infection. The differentially expressed mRNAs were involved in several different biological pathways 
where immunological networks were most enriched. Importantly, we discovered that HIV induces 
expression reversal of more than 150 lncRNAs between its active and latent infection. Also, hundreds of 
unique lncRNAs were identified in both infection conditions. The pathology specific “gene-expression 
reversal” and “on-and-off” switching of lncRNAs and associated mRNAs may lead to establish the 
relationship between active and HIV infection.
The highly active antiretroviral therapy (HAART) can certainly decrease the plasma viral load below the detec-
tion limit; however, complete elimination of HIV infection remains far out of reach. The major hindrance in this 
direction is the latent HIV infection in cell subpopulations where anti-HIV drugs and immune clearance is not 
effective. HIV can persist in these viral reservoirs for years with little or no productive infection and can reactivate 
later1. In contrast to initial belief, latent HIV reservoirs are present beyond the realm of memory CD4+ T cells2–5. 
Subpopulations of all kind of immune cells such as dendritic cells, hematopoietic progenitor cells, natural killer 
cells, mast cells, monocytes, macrophages, etc. also serve as HIV reservoirs. It is noteworthy to mention that 
infected/non-infected cells of monocyte-macrophage lineage naturally transmigrate to brain from peripheral 
circulation and vice-versa. This results in HIV dissemination into brain. CNS is also reported to be a major site 
of HIV reservoir2,6. Thus, macrophages/monocytes serve as major connecting link between peripheral and brain 
infection of HIV, be it active or latent7. It has been widely accepted that HIV latency is driven by multitude of 
epigenetic-based transcriptional factors after integration of pro-viral genomes into the host genome8–10. Role of 
histone modifications such as acetylation, methylation, etc. in HIV latency have already been shown in several 
studies11–14. However, these factors proved not more than a fractional player and despite intensive efforts by global 
scientific community during last decade, the molecular essence of HIV latency still remains indistinct.
The epigenetic landscape - beyond histone modifications - is extended deep into the genomic “dark matter”. 
This refers to non-protein-coding RNAs which comprises nearly 70% of genome. These are categorized into 
small and long non-coding RNAs (lncRNAs) with later being > 200nt in length15. Similarly, plethora of research 
suggest possible role of one or more microRNAs (miRNAs) in the HIV latency16. While vast majority of small 
non-coding RNAs (e.g. miRNAs) are being researched over a decade, functional role of lncRNAs has com-
menced only recently. Human genome is expected to have more than 23,000 lncRNAs that can regulate various 
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transcriptional and posttranscriptional processes17. The complex paradigm of lncRNAs as epigenetic modulators 
is fast being revealed. Many lncRNAs signatures display intimate connection with histone proteins associated epi-
genetic marks. These can tune the chromatin activation/repression and chromosomal looping18. Also, lncRNAs 
can guide gene-silencing via targeted recruitment of epigenetic silencing complexes in the promoter region and 
suppression of lncRNAs has been shown to activate their targeted protein-coding gene19. The lncRNAs can func-
tion both, in trans and in cis i.e. when their targeted genes are located on different and same allele, respectively15. 
Thus, as an endogenous effector molecule, lncRNAs show remarkable influence on epigenetic regulations with a 
surprising degree of complexity.
Most pathogens are adept at altering host gene expression in their favor by controlling replication, transcrip-
tion, and/or translation processes. As such, modulation of lncRNAs – which is emerging as a vital player at 
transcriptional and post-transcriptional level – may be a critical point of manipulation by obligate parasites such 
as HIV. In fact, few existing reports at this point suggests role of lncRNAs in activation of HIV replication and 
subsequent increase in virus production as well20–22. This provides a clue that defining lncRNAs contribution 
in HIV biogenesis may represent tools needed to beat the enigma behind latent and active infection. To best of 
our knowledge no studies, to-date, have been conducted to delineate variations in the lncRNAs profile between 
an active and latent HIV infection. Using microarray analysis we hereby, for the first time, report that active 
and latent HIV infection results in differential pattern of lncRNAs and mRNAs expression. Gene ontology and 
pathways analysis of upregulated and downregulated transcripts showed their relevance to several metabolic and 
biological processes. While both, active and latent infection shared common upregulated and downregulated 
lncRNAs and mRNAs in compare to uninfected control, majority of them were uniquely expressed in both infec-
tions scenario. Importantly, a big chunk of these lncRNAs and mRNAs showed expression reversal when com-
pared between active and latent infection and vice-versa. Also, more than one thousands of both, lncRNAs and 
their associated mRNAs were differentially expressed in active and/or latent infection. As such, this study may 
lead to decode illusionary linkage driving the HIV latency, which continues to be the biggest stumbling block in 
developing successful antiretroviral drug cocktails.
Materials and Methods
HIV infection and RNA isolation. The U-937 monocytes (American Type Culture Collection) and pro-
monocytic U1 latent cells (AIDS Research and Reference Reagent Program, NIAID, National Institute of Health, 
Rockville, MD, catalog no. 165) were used to perform active and latent infection model, respectively. U1 is a 
subclone of U937 that has been chronically infected with HIV-1, and show minimal constitutive expression of 
virus. The U-937 monocytes were infected with 100 ng/ml HIV-1Ba-L(NIH AIDS Research and Reference Reagent 
Program catalog no. 510). After 5 days of infection, RNA were isolated using the RNeasy mini kit (Qiagen, 
Limburg, the Netherlands) according to the manufacturer’s guidelines.
LncRNAs Microarray analysis. For lncRNAs microarray analysis, Agilent Array platform was employed. 
The sample preparation and microarray hybridization were performed based on the manufacturer’s stand-
ard protocols with minor modifications. Briefly, mRNA was purified from total RNA after removal of rRNA 
(mRNA-ONLY™ Eukaryotic mRNA Isolation Kit, Epicentre). Then, each sample was amplified and transcribed 
into fluorescent cRNA along the entire length of the transcripts without 3′ bias utilizing a mixture of oligo(dT) 
and random primers (Arraystar Flash RNA Labeling Kit, Arraystar). The labeled cRNAs were hybridized onto 
the Human LncRNA Array v3.0 (8 × 60 K, Arraystar). Arraystar Human LncRNA Microarray V3.0 is designed 
for the global profiling of about 30,586 human LncRNAs. The LncRNAs are carefully constructed using the most 
highly-respected public transcriptome databases (Refseq, UCSC knowngenes, Gencode, etc), as well as landmark 
publications. Each transcript is represented by a specific exon or splice junction probe which can identify indi-
vidual transcript accurately. Positive probes for housekeeping genes and negative probes are also printed onto the 
array for hybridization quality control. After having washed the slides, the arrays were scanned by the Agilent 
Scanner G2505C. Agilent Feature Extraction software (version 11.0.1.1) was used to analyze acquired array 
images. Quantile normalization and subsequent data processing were performed using the GeneSpring GX v12.1 
software package (Agilent Technologies). After quantile normalization of the raw data, LncRNAs that at least 4 
out of 12 samples have flags in Present or Marginal were chosen for differentially expressed LncRNAs screening.
Analysis of mRNAs microarray. Sample preparation, RNA labeling, and array hybridization were similar 
to that explained for lncRNAs microarray in above section. Arraystar Human Microarray V3.0 is designed for the 
global profiling of about 26,109 coding transcripts. After quantile normalization of the raw data, mRNAs that at 
least 4 out of 12 samples have flags in Present or Marginal was chosen for differentially expressed mRNAs screen-
ing. The GO categories for differentially expressed mRNAs were derived from Gene Ontology (http://www.gene-
ontology.org), which comprise three structured networks of defined terms that describe gene product attributes. 
The pathway analysis for differentially expressed mRNAs was based on the latest KEGG (Kyoto Encyclopedia of 
Genes and Genomes, (http://www.genome.jp/kegg) database.
Statistics. Quality assessment of LncRNAs and mRNAs data after filtering was performed using box-plot. 
The Box Plot was used for comparing the distributions of the intensities from all samples. After normalization, the 
distributions of log2-ratios among all tested samples were nearly the same. For screening differentially expression, 
lncRNAs and mRNAs that passed Volcano Plot filtering (Fold Change > = 2.0 and P-value < = 0.05) was consid-
ered statistically significance. The P-value cut-off for both GO term and pathways is 0.05.
Results
Uniquely modulated and shared lncRNAs between active vs latent HIV infection. To gain 
an understanding of epigenetics complexity of HIV infection, active and latently infected macrophages were 
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subjected for lncRNAs expression profiling. Figure 1A,B shows the volcano plots for the differential expression 
of lncRNAs in uninfected vs active infection and uninfected vs latent infection respectively. Based on microarray 
analysis, 795 lncRNAs were found downregulated (Fig. 1C) and 389 lncRNAs were found upregulated (Fig. 1D) 
during the active infection, when compared to uninfected control. In case of latent infection, no. of downregu-
lated and upregulated lncRNAs were 1809 (Fig. 1C) and 2719 (Fig. 1D), respectively. Inclusion of upregulated or 
downregulated lncRNAs was based on at least 2 fold modulation of their gene expression with p-value of 0.05. A 
total of 439 downregulated (Fig. 1C) and 137 upregulated (Fig. 1D) lncRNAs were found common in both active 
and latent infection. As such, several lncRNAs were specifically downregulated and upregulated in active and 
latent infection. During active infection, 356 (Fig. 1C) and 252 (Fig. 1D) lncRNAs were uniquely downregulated 
and upregulated, respectively. Similarly, 1370 (Fig. 1C) and 2582 (Fig. 1D) lncRNAs were respectively downregu-
lated and upregulated during latent infection.
Uniquely modulated and shared mRNAs between active vs latent HIV infection. Similar to 
lncRNAs expression pattern, several protein-coding gene expression modulations were specific to either latent 
or active infections and many upregulated and downregulated transcripts were common to both conditions as 
well. Figure 2A,B represents the volcano plots for the differential expression of mRNAs in uninfected vs active 
infection and uninfected vs latent infection respectively. In comparison to uninfected control, active infections 
resulted in downregulation of 595 mRNAs (Fig. 2C) and upregulation of 530 mRNAs (Fig. 2D). The latent infec-
tion resulted in downregulation of 3905 mRNAs (Fig. 2C) and upregulation of 3233 mRNAs (Fig. 2D). Again, 
inclusion of upregulated or downregulated mRNAs was based on their higher or lower expression by at least 2 
Figure 1. (A,B) Volcano plots of the two samples t-tests of lncRNAs expression fold change for active (A) and 
latent (B) HIV infections in macrophages in compare to uninfected control: It shows differentially expressed 
lncRNAs with statistical significance that passed Volcano Plot filtering (Fold Change > = 2.0 and P-value < = 0.05). 
The vertical yellow lines correspond to 2.0-fold up and down and the horizontal yellow line represents a P-value 
up to 0.05. So the red cubes in the plot represent the differentially expressed lncRNAs with statistical significance. 
(C,D) Venn diagram showing no of common downregulated (C) and upregulated (D) lncRNAs in active vs latent 
infection.
www.nature.com/scientificreports/
4Scientific RepoRts | 6:34862 | DOI: 10.1038/srep34862
fold and having p-value of 0.05. Off these modulated protein-coding genes, 426 downregulated (Fig. 2C) and 220 
(Fig. 2D) upregulated mRNAs were common to both active and latent infections. As such, 169 downregulated 
mRNAs (Fig. 2C) and 310 upregulated mRNAs (Fig. 2D) were specific to active infection and 3479 downregulated 
mRNAs (Fig. 2C) and 3013 upregulated mRNAs (Fig. 2D) were specific to latent condition. Details of all modu-
lated mRNAs have been given in supplementary data 2.
Differentially expressed mRNAs belonging to both active and latent infection were subjected to GO 
(Supplementary figures 1) and pathway analysis (Fig. 3). GO analysis of transcripts was annotated under three 
ontological categories, namely, biological process, cellular component, and molecular function. The significance 
of GO term enrichment in the differentially expressed transcripts was estimated based on p values ≤ 0.05. As 
expected, different “most highly enriched GO terms” for active and latent infection were found (Supplementary 
figures 1A-D) because – despite numbers of common upregulated and downregulated mRNAs between active 
and latent infection – large fraction was specific to either infection condition (Figs 1C,D and 2C,D). Details of 
each GO term are given in supplementary data 3 and the GO associations of each upregulated and downregulated 
transcript are given in supplementary data 2.
Moreover, pathways analysis showed that the modulated genes are involved in 155 different pathways ((data 
not included). This analysis allows determining the biological pathway in which there is a significant enrichment 
of differentially expressed mRNAs; and again the p-value ≤ 0.05 denotes the significance of the Pathway (Fig. 3). 
Again, active and latent infection showed different “most enriched network” (Fig. 3A–D). Immunological net-
works such as cytokine-cytokine receptor interaction, chemokine signaling pathway, TNF signaling pathway, 
Toll-like receptor signaling pathway, Rheumatoid arthritis pathway, NF-kappa B singling pathway, and leukocyte 
transendothelial migration pathway were found among most enriched network in active infection corresponding 
Figure 2. (A,B) Volcano plots of the two samples t-tests of mRNAs expression fold change for active (A) and 
latent (B) HIV infections in macrophages in compare to uninfected control: It shows differentially expressed 
lncRNAs with statistical significance that passed Volcano Plot filtering (Fold Change > = 2.0 and P-value < = 0.05). 
The vertical yellow lines correspond to 2.0-fold up and down and the horizontal yellow line represents a P-value 
up to 0.05. So the red cubes in the plot represent the differentially expressed mRNAs with statistical significance. 
(C,D) Venn diagram showing no of common downregulated (C) and upregulated (D) lncRNAs in active vs latent 
infection.
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to upregulated genes (Fig. 3A). The pathway corresponding to downregulated mRNAs during active condition 
also included inflammatory pathways such as Rig-I-like receptor signaling pathway, cytokine-cytokine recep-
tor interaction, lupus erythematosus, and cytosolic DNA-sending pathway (Fig. 3B). In the latent infection cor-
responding to upregulated mRNAs, immunological pathways such as lysosome pathway, chemokine signaling 
pathway, Toll-like receptor signaling pathway, Phagosome pathway, etc. were enriched (Fig. 3C). Interestingly, 
downregulated genes in latent infection showed enrichment of replication associated pathways such as, DNA 
replication pathway, RNA transport pathway, Nucleotide excision pathway, Spliceosome pathway, and Pyrimidine 
metabolism (Fig. 3D). Some HIV associated secondary infection pathway, such as, salmonella infection, influenza 
infection, herpes simplex virus infection, tuberculosis, pertussis, hepatitis B, staphylococcus infection, etc. are 
also enriched across both active and latent infection.
Expression reversal of lncRNAs and mRNAs between active vs latent HIV infection. We wanted 
to examine if HIV induces certain gene expression during active infection which are suppressed in latent infec-
tion or vice-versa. Interestingly, the gene expression reversal between active and latent infections was found at 
both lncRNAs and mRNAs level (Fig. 4). While 94 lncRNAs upregulated in latent infection were downregulated 
in active infection (Fig. 4A), 60 downregulated lncRNAs in latent infection were upregulated in active infec-
tion (Fig. 4B). As such, a total of 154 lncRNAs showed expression reversal between both infection conditions. 
Similarly 179 mRNAs were expressed inversely in active and latent infection: 63 downregulated 116 upregulated 
mRNAs in active infection were respectively downregulated and upregulated in latent infection (Fig. 4C,D). 
Details of lncRNAs and mRNAs showing expression reversal have been given in supplementary data 4.
Figure 3. Pathway analyses of differentially expressed mRNAs were based on latest KEGG (Kyoto 
Encyclopedia of Genes and Genomes, http://www.genome.jp/kegg) database. Most enriched pathway of 
upregulated (A) and downregulated (B) mRNAs in active infection condition was dominated by immunological 
networks. Pathway corresponding to upregulated mRNAs in latent infection (C) also includes many 
immunological networks and pathway corresponding to downregulated mRNAs in latent infection (D) showed 
enrichment of replication associated pathways. These differentially expressed mRNAs are associated with 155 
biological pathways (Supplementary figure 2), where nodes with red color denotes significant association.
www.nature.com/scientificreports/
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Association between differentially expressed lncRNAs and mRNAs. To establish the pattern of 
interplay between lncRNAs and their associated mRNAs, we analyzed if both RNAs category were differentially 
expressed in active and/or latent infection. We found 1068 such pair with parallel (lncRNAs upregulation/down-
regualtion = > mRNAs upregulation/downregulation) and/or reverse expression (lncRNAs upregulation/down-
regualtion = > mRNAs downregulation/upregulation) pattern. All differentially expressed “lncRNAs – mRNAs” 
pair is denoted in Figs 5, 6, 7 and 8. While role of these lncRNAs remain undiscovered, several mRNAs from such 
pair have been implicated in HIV infection.
Discussion
HIV latency is a state of replication restriction when either few viruses are reproduced or viruses are reproduced inter-
mittently. The quantitative and/or temporal dimension of establishment of HIV persistence is determined by many fac-
tors such as cell’s life span, their infection susceptibility and proliferative ability, alterations in cellular physiology and/or 
immunologic controls, etc. Cells of monocyte/macrophages lineage is one of the principal targets of HIV among others. 
These cells are more resistant - than CD4+ T or other cells - to the cytopathic effect induced via apoptosis during HIV 
infection. In turn, they make more stable hideouts and can harbor HIV for longer time. As an important viral reservoir, 
macrophages can disseminate HIV across all organ systems because of its universal presence in body23. A decade of 
efforts made in the direction of eliminating HIV reservoirs is strongly suggesting towards involvement of unknown, 
sophisticated epigenetic regulatory machinery that is beyond known landscape of histone modifications and small 
non-coding RNAs such as miRNAs. The complex paradigm of lncRNAs-based transcriptional and post-transcriptional 
gene regulation is gradually being unfolded and evidences insinuate them as a central player in driving epigenetic 
remodeling in different non-viral24 and viral disease systems such as SARS corona virus, influenza virus, Marek’s dis-
ease virus, herpes simplex virus, etc.17. Couple of recent studies shows specific lncRNA-based modulation of HIV rep-
lication. Nonetheless, lncRNAs in these studies were selected based on their role in other diseases21,22. Another study by 
Saayman et al.24 examined HIV-encoded antisense lncRNAs in epigenetic control of HIV transcriptions. Discovery of 
new, physiologically relevant lncRNAs continues to rise in human cells and as such examining one or few dozen lncR-
NAs from other disorders may little reflect the cumulative intensities about their role in HIV infection. In this microar-
ray analysis, we profiled global lncRNAs in both active and latent infection. With a profiling ability of 30,586 human 
LncRNAs, our assay could detect 1184 differentially expressed lncRNAs in active infection and 4523 differentially 
Figure 4. Gene expression reversal: Venn analysis showing number of those lncRNAs (A,B) and mRNAs 
(C,D) which were both downregulated and upregulated in active vs latent infection and vice versa. It was 
found that 94 lncRNAs downregulated in active infection were also upregulated in latent infection (A) and 60 
lncRNAs upregulated in active infection were also downregulated in latent infection (B). Similarly, 63 mRNAs 
downregulated in active infection were also upregulated in latent infection and 116 mRNAs upregulated in 
active infection were also downregulated in latent infection. Details of these lncRNAs and mRNAs are given in 
supplementary data 1 and 2, respectively.
www.nature.com/scientificreports/
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Figure 5. Interplay between differentially expressed lncRNAs and their associated mRNAs: A1: Pairs of 
lncRNAs downregulated in active infection and mRNAs downregulated and upregulated in active infection;  
A2: Pairs of lncRNAs downregulated in active infection and mRNAs upregulated in latent infection; A3: Pairs  
of lncRNAs downregulated in active infection and mRNAs downregulated in latent infection.
Figure 6. A1: Pairs of lncRNAs upregulated in active infection and mRNAs downregulated and upregulated 
in active infection; A2: Pairs of lncRNAs upregulated in active infection and mRNAs downregulated in latent 
infection. A3: Pair of lncRNAs upregulated in active infection and mRNAs upregulated in latent infection.
www.nature.com/scientificreports/
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Figure 7. A1: Pairs of lncRNAs downregulated in latent infection and mRNAs downregulated in active infection; 
A2: Pairs of lncRNAs downregulated in latent infection and mRNAs upregulated in active infection; A3: 1–4: Pairs 
of lncRNAs downregulated in latent infection and mRNAs downregulated in latent infection; A4: Pairs of lncRNAs 
downregulated in latent infection and mRNAs upregulated in latent infection.
www.nature.com/scientificreports/
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expressed lncRNAs in latent infection. This difference in the no. of lncRNAs between active and latent infection may 
be attributed to the differences in the degree or intensity of epigenetic modifications during respective infection 
stages. The continued transcriptional suppression of HIV genome post-integration, for latency maintenance, may 
require greater degree of epigenomic involvement compared to active infection where epigenomic alterations may 
be of little significance. Moreover, intrinsic transcriptional originality of the cell lines may also partially contribute 
to these differences because promonocytic U1 latent cells, a subclone of U937, are chronically infected with HIV-1 
compared to U-937 monocytes used for active HIV-1 infection. Many of these lncRNAs were specifically modu-
lated during active or latent infection. Nonetheless a big amount of them were either upregulated or downregulated 
in both infection scenarios. These variations in lncRNAs expression between two different HIV infection condi-
tions further substantiate the greater role of epigenetic regulators and that lncRNAs may have specific “on-and-off” 
switching mechanism to drive latent or active condition. Understanding such mechanism – if exists – can better be 
revealed by knowing their chromosomal locations and its relationship with nearby coding gene. We found that these 
modulated lncRNAs during HIV active or latent infection are distributed on both “+ ” and “− ” strand of different 
chromosomes and belongs to all groups: intergenic, intron sense-overlapping, exon-sense overlapping, natural anti-
sense, intronic antisense, and bidirectional (supplementary data 1). This knowledge can certainly be helpful in 
determining lncRNAs associated host factors responsible for guiding epigenetic remodeling.
Figure 8. A1: Pairs of lncRNAs upregulated in latent infection and mRNAs downregulated in active infection; 
A2: Pairs of lncRNAs upregulated in latent infection and mRNAs upregulated in active infection; A3: 1–2: Pairs 
of lncRNAs upregulated in latent infection and mRNAs downregulated in latent infection; A4: 1–5: Pairs of 
lncRNAs upregulated in latent infection and mRNAs upregulated in latent infection.
www.nature.com/scientificreports/
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A more holistic understanding of lncRNAs mechanism requires establishing their association with 
mRNAs. Several studies have shown that lncRNAs can behave as transcription enhancer or suppressor in an 
orientation-independent or dependent manner25. As such, we first established global profiling of mRNAs in 
both active and latent infection. With a profiling ability of 26,109 coding transcripts, we found 1125 and 7138 
mRNAs differentially modulated during active and latent infection, respectively. Similar to lncRNAs, modulated 
mRNAs were specific to and shared by active and latent infection. This quantitative pattern of mRNA modula-
tions between active and latent infection is in parallel with that of lncRNAs suggesting high degree of lncRNAs 
involvement in epigenetic modifications and subsequent transcriptional control. Importantly, this raises the pos-
sibility that HIV may induce parallel manipulation of lncRNAs and mRNAs as a mechanism to dominate host 
cellular machinery. Nonetheless, this parallel manipulation may exist for both unrelated or closely associated 
lncRNAs and mRNAs. We could establish about 1068 lncRNAs and associated mRNAs pair modulated during 
HIV active and/or latent infection. Role of lncRNAs in regulation of marker genes have been established in other 
diseases25. In fact, several of mRNAs from the modulated “lncRNAs-mRNAs” pair have been established in the 
HIV infection. For example, Histone deacetylase (HDAC) regulates transcription of numerous cellular and viral 
genes. It has been shown that the class I HDACs, HDAC1, − 2, and − 3, are recruited to the HIV-1 LTR in cell 
line models of HIV-1 latency26. The sub-class I selective inhibitors for HDAC1, − 2, and − 3 have shown to induce 
latent HIV-1 expression strongly in resting CD4 + T cells27. Moreover, tat induced upregulation of HDAC2 are 
also reported to induce transcriptional repression leading to neurocognitive impairment28. The RUNX protein, 
which works in combination with the co-factor CBF-β , function as critical transcriptional regulators in T-cells29. 
RUNX1 bind DNA sequences within the HIV-1 LTR repressing the transcription. Lower expression of BDNF 
has been reported in HIV-infected individuals with HAD than in non-demented HIV30. The decrease in BDNF 
evoked by HIV is believed to contribute to the development of synaptic simplification and neuronal damage 
seen in HAD. BRCA1, which is present at the HIV-1 LTR in a highly relevant model of HIV infection, is another 
protein found to be important for viral transcription. The cells that lack BRCA1 have severely reduced HIV-1 
Tat-dependent transcription31. Gain or loss-of-function studies have shown to enhance or decrease transcription. 
Moreover, BRCA1 has been shown to be in complex with pTEF-b, and Cyclin T1 has been shown to be an essen-
tial factor for BRCA1-dependent activation of RNAP II transcription.
Similarly, other modulated mRNAs also regulates HIV infection in one or other way. In fact, pathways and 
gene ontology analysis shows their involvement in 155 biological cycles where majority of enriched network 
belonged to immunological and inflammatory significance. This was expected because most infection including 
that by HIV induces immunological and inflammatory defense signaling. HIV infection induces various second-
ary infections and therefore enrichment of network associated with salmonella infection, influenza infection, 
herpes simplex virus infection, tuberculosis, pertussis, hepatitis B, staphylococcus infection, etc. may imply the 
likelihood of such opportunistic infections during HIV pathogenesis. Interestingly, enrichment of replication 
associated pathways (such as RNA transport pathway, Nucleotide excision pathway, Spliceosome pathway, and 
Pyrimidine metabolism, etc.) during latent infection suggest towards a highly sophisticated and regressive epi-
genetics overhauling in compare to active infection. This is also reflected in the quantitative differences of the 
total differentially expressed lncRNAs and mRNAs between active and latent infection. Now challenge ahead is 
to examine pathophysiological significant of these closely associated, differential expressed “lncRNAs-mRNAs” 
pair one by one. Nonetheless, active and latent stages are two opposite facet of the HIV infection and there-
fore, expression reversal of a specific gene set (Active upregulation/downregualtion < = > latent downregulation/
upregulation) between these two conditions cannot be excluded. It is possible that expression reversal of certain 
genes between active and latent infection, independently or together with the active and latent infection-specific 
uniquely modulated genes, can have remarkable pathophysiological significance. Genetic commonality (close 
association) may potentiate susceptibility of other related disorders. In fact, copy number variants and temporal 
expression differences of a specific gene associated with one neurological and autoimmune disorder can predis-
pose to others32. Thus, driver of latent infection of HIV may find its epigenetic origin in active infection.
A correlation at the interface of two different pathological condition of same disease can be drawn with the 
discovery of multiple epigenetic signatures. Disrupted expression of even a single coding or non-coding gene pos-
sesses ability to affect multiple molecular pathways and as such, different pathological phenotypes may entangle 
in converged molecular circuits. Interpretation of underlying disease mechanism(s) based on single gene annota-
tion often proved to be less comprehensive33. Thus, discoveries of a set of unique or shared dysregulated molecular 
markers between active and latent HIV infection can accelerate studies on their pathophysiologic mechanisms 
and in turn can lead to disease-modifying therapy. Nonetheless, defining cell-specific epigenetic modulations can 
only represent a small subset when their arrangements are also dictated on the basis of neighboring cell connec-
tivity, morphology, and physiological properties34. Exploratory follow-up of our macrophage specific findings 
- involving clinical resolution – will substantiate the lncRNAs-mRNAs functional similarities or dissimilarities 
between active and latent infections.
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